Related Experiment Video
Updated: May 16, 2026

05:33
Isolation of Soil Microorganisms Using iChip Technology
Published on: January 10, 2025
Antimicrobials, drug discovery, and genome mining
R J Scheffler1, S Colmer, H Tynan
1Research Institute for Scientists Emeriti (R.I.S.E.), Drew University, 07940, Madison, NJ, USA.
Applied Microbiology and Biotechnology
|December 13, 2012
Summary
The rise of antibiotic-resistant bacteria like MRSA necessitates new drugs. Genome mining offers a promising approach to discover novel antibiotics, addressing a critical global health challenge.
Area of Science:
- Microbiology
- Pharmacology
- Genomics
Background:
- Antibiotics have been crucial for treating microbial diseases.
- Increasing antibiotic resistance in pathogens like methicillin-resistant Staphylococcus aureus (MRSA) poses a significant threat.
- Pharmaceutical companies have reduced antibiotic research, exacerbating the drug discovery gap.
Purpose of the Study:
- To highlight the urgent need for novel antibiotics due to rising antimicrobial resistance.
- To explore innovative strategies for antibiotic discovery and development.
Main Methods:
- Review of current challenges in antibiotic development.
- Application of genome mining techniques leveraging advancements in genome sequencing.
Main Results:
- Identification of potential new antibiotic candidates through genome mining.
- Genome sequencing provides a powerful tool for discovering novel antimicrobial compounds.
Conclusions:
- Genome mining presents a viable and hopeful strategy for discovering new antibiotics.
- Addressing the antibiotic resistance crisis requires continued innovation in drug discovery.
Related Concept Videos
Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Automated Microbial Diagnostics
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
Modern Molecular Taxonomy
Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...
